Albuquerque, NM — Sandia Biotech, Inc. announced today that the company has signed an exclusive option agreement with STC.UNM (STC) for a technology developed by researchers at the University of New Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary University of London in London, England. The group of technologies, called the Recombinant Fluorescent Antibody […]
On September 11, 2014, BGI, Imperial College London and Waters Corporation signed a framework agreement in Shenzhen, China. Liangyu Zhang, CEO of Greater China of Waters Corporation, Vince Gao, CEO of BGI Heath, and representatives of Imperial College London attended the signing ceremony. The collaboration brings together three of the leading scientific groups in the […]
CORNING, N.Y. -– Corning Incorporated (NYSE: GLW) today announced it has entered into an agreement with BioLamina to manufacture and package the Recombinant Laminin-521 (rLaminin-521) pluripotent stem-cell and neural stem-cell growth matrix. The collaboration will augment Corning Life Sciences’ industry-leading portfolio of defined coating substrates and extend the availability of this product to research labs […]
Kelso, UK and Woking, UK –- Plexus Corp. (NASDAQ: PLXS), a global provider of optimised Product Realization solutions, and Microsaic Systems (AIM: MSYS), the developer of chip-based scientific instruments, have entered an agreement for Plexus to provide design and manufacturing solutions from its UK facilities. Plexus will support Microsaic with the manufacture of its 4000 […]
RADNOR, PA — VWR International, LLC, a leading independent provider of laboratory supplies, equipment and services to the global life science and research industries, announced today that it has acquired Klinipath BV and its affiliates Immunologic BV, Mortupath BV and Klinipath BVBA. This acquisition further extends VWR’s capabilities and portfolio in histology, immunology and clinical […]
JENA/Germany, WASHINGTON D.C./USA — The National Institutes of Health (NIH) announced its first research grants through President Barack Obama’s BRAIN Initiative, including three awards to the University of California, Berkeley, totaling nearly $7.5 million over three years. In addition, a $12 million public-private collaboration between ZEISS and UC Berkeley to support the Berkeley Brain Microscopy […]
JENA/Germany, Maryland/USA — ZEISS and the Howard Hughes Medical Institute’s Janelia Research Campus have signed an exclusive license agreement for the commercialization of Bessel beam plane illumination microscopy, also called lattice light sheet microscopy. The fluorescence imaging method was invented by Dr. Eric Betzig, group leader at the Janelia Research Campus in Ashburn, Virginia, USA. […]
YOKOHAMA, Japan — ReproCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the ReproCELL Group to expand the product lineups of its iPS Cell Business and establish technical advantages, promoting great differentiation. Stemgent has succeeded in launching many worldwide leading iPS cell research reagent products including […]
BOSTON & SEATTLE & HOUSTON & NEW YORK & SAN DIEGO — World-renowned cancer centers and Illumina, Inc. (NASDAQ:ILMN) today announced the formation of the Actionable Genome Consortium (AGC), an effort to recommend openly published standards for the widespread use of next-generation sequencing to guide decision-making in clinical oncology. The core remit of the AGC […]
Victoria, BC — GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers. Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
